These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 823389)

  • 1. An animal behavior model for studying central serotonergic synapses.
    Jacobs BL
    Life Sci; 1976 Sep; 19(6):777-85. PubMed ID: 823389
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of monoamine oxidase inhibitors on phencylidine induced stereotyped behavior and brain levels in rats.
    Murray TF; Horita A
    Proc West Pharmacol Soc; 1979; 22():145-7. PubMed ID: 574645
    [No Abstract]   [Full Text] [Related]  

  • 3. The effects of drugs on serotonergic nerve terminals.
    Bloom FE; Costa E
    Adv Cytopharmacol; 1971 May; 1():379-95. PubMed ID: 5163249
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative aspects of selected psychoactive compounds: biogenic amines, monoamine oxidase inhibitors, and lysergic acid diethylamide.
    Pscheidt GR
    Comp Biochem Physiol; 1968 Jan; 24(1):249-65. PubMed ID: 4868883
    [No Abstract]   [Full Text] [Related]  

  • 5. Dopaminergic mechanisms and stereotyped behaviour in birds.
    Nistico' G; Stephenson JD
    Pharmacol Res Commun; 1979 Jul; 11(7):555-70. PubMed ID: 116248
    [No Abstract]   [Full Text] [Related]  

  • 6. Antagonism of beta-phenylethylamine derivatives and serotonin blocking drugs upon serotonin, tryptamine and reserpine behavioral depression in mice.
    Saavedra JM; Fischer E
    Arzneimittelforschung; 1970 Jul; 20(7):952-7. PubMed ID: 5536068
    [No Abstract]   [Full Text] [Related]  

  • 7. Interaction of ergot drugs with central monoamine systems. Evidence for a high potential in the treatment of mental and neurological disorders.
    Fuxe K; Fredholm BB; Agnati LF; Ogren SO; Everitt BJ; Jonsson G; Gustafsson JA
    Pharmacology; 1978; 16 Suppl 1():99-134. PubMed ID: 643908
    [No Abstract]   [Full Text] [Related]  

  • 8. SL25.1131 [3(S),3a(S)-3-methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one], a new, reversible, and mixed inhibitor of monoamine oxidase-A and monoamine oxidase-B: biochemical and behavioral profile.
    Aubin N; Barneoud P; Carter C; Caille D; Sontag N; Marc C; Lolivier J; Gardes A; Perron C; Le Kim A; Charieras T; Pandini M; Burnier P; Puech F; Jegham S; George P; Scatton B; Curet O
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1171-82. PubMed ID: 15178694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of drugs on the firing of serotonin-containing neurons in brain.
    Aghajanian GK
    Fed Proc; 1972; 31(1):91-6. PubMed ID: 4333252
    [No Abstract]   [Full Text] [Related]  

  • 10. Serotonin-containing neurons in brain: depression of firing by monoamine oxidase inhibitors.
    Aghajanian GK; Graham AW; Sheard MH
    Science; 1970 Sep; 169(3950):1100-2. PubMed ID: 5449322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Stereotyped behavior and the nigro-strio-nigral system].
    Arushanian EB
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1985; 35(5):819-32. PubMed ID: 2866641
    [No Abstract]   [Full Text] [Related]  

  • 12. Behavioral correlates of dopaminergic supersensitivity.
    Iversen SD; Creese I
    Adv Neurol; 1975; 9():81-92. PubMed ID: 1170717
    [No Abstract]   [Full Text] [Related]  

  • 13. Serotonin binding to nerve ending particles and other preparations from rat brain.
    Marchbanks RM
    J Neurochem; 1966 Dec; 13(12):1481-93. PubMed ID: 5962026
    [No Abstract]   [Full Text] [Related]  

  • 14. [Stereotyped movements and substantia nigra-corpus striatum dopaminergic function in the rat: action of methylphenidate after inhibition of monoamine oxidase].
    Duteil J; de Sereville JE; Multon MF; Pessonnier J; Rambert FA
    Ann Pharm Fr; 1987; 45(1):25-34. PubMed ID: 3662339
    [No Abstract]   [Full Text] [Related]  

  • 15. Turning behaviour in animals.
    Pycock CJ
    Neuroscience; 1980; 5(3):461-514. PubMed ID: 6154905
    [No Abstract]   [Full Text] [Related]  

  • 16. Serotonergic component of neuroleptic receptors.
    Leysen JE; Niemegeers CJ; Tollenaere JP; Laduron PM
    Nature; 1978 Mar; 272(5649):168-71. PubMed ID: 564466
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of manipulating pallidal and nigral GABA on striatally-mediated head-turning in the rat [proceedings].
    Crossman AR; Lee LA; Slater P
    Br J Pharmacol; 1977 Nov; 61(3):483P. PubMed ID: 563262
    [No Abstract]   [Full Text] [Related]  

  • 18. [Role of the serotoninergic raphe-hippocampus system for the antinocifensive effect of morphine].
    Dude C; Dude G; Andreas K
    Acta Biol Med Ger; 1979; 38(4):641-7. PubMed ID: 525141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of 5-HT in the action of some drugs affecting extrapyramidal system.
    Gumulka W; Kostowski W; Czlonkowski A
    Pharmacology; 1973; 10(6):363-72. PubMed ID: 4274062
    [No Abstract]   [Full Text] [Related]  

  • 20. One-trial conditioned rotation in rats.
    Silverman PB
    NIDA Res Monogr; 1989; 95():540-1. PubMed ID: 2577050
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.